A marine pharmacology seminar presentation has been developed by Dr. Mayer that covers: (1) the preclinical pipeline (marine natural products with antitumor and cytotoxic activity, as well as other pharmacological activities); (2) the clinical pipeline; and, (3) FDA-approved marine pharmaceuticals. This seminar presentation is being updated on a regular basis and has been presented at the scientific meetings and universities shown below.

Mayer, A.M.S. The global marine pharmacology pipeline. Chemistry Institute of São Carlos, University of São Paulo at São Carlos, Brasil. November 23, 2009.

Mayer, A.M.S. The global marine pharmacology pipeline. Experimental Biology 2009. ASPET Symposium: A Renaissance in Marine Pharmacology: Preclinical Curiosity to Clinical Reality. New Orleans, Louisiana, April 19, 2009.

Mayer, A.M.S.  Marine Pharmacology: FDA-approved marine drugs, and the marine clinical and preclinical pipeline. Florida International University Graduate School and Marine Sciences Program. Miami, Florida, January 30, 2009.

Mayer, A.M.S.  Marine Pharmacology: A Critique of the Preclinical and Clinical Literature. University of Puerto Rico, Rio Piedras Campus, Department of Chemistry, January 28, 2008.

Mayer, A.M.S.  Marine Pharmacology: A Critique of the Preclinical and Clinical Literature. American Association of Pharmaceutical Scientists, San Diego, California. November 13, 2007.

Please email Dr. Mayer at amayer@midwestern.edu for further information. Thank you.

Copyright © 2005-2009 Midwestern University. Last Rev. 11/30/2009. Direct questions or comments to Site Coordinator